Alnylam Pharmaceuticals


Alnylam Pharmaceuticals Stock Quote
$78.97 $1.33 1.7%
BATS BZX Real Time Price as of October 11, 2019, 4:00 p.m. EDT View Interactive ALNY Charts

A biopharmaceutical company developing novel therapeutics based on RNA interference, which is a naturally occurring biological pathway within cells for selectively silencing and regulating specific genes.

News & Analysis: Alnylam Pharmaceuticals

The Fool has written over 200 articles on Alnylam Pharmaceuticals.


Market Moves



2 Biotechs With Big Dates in April

Here's what you need to know about two biotechs that will present trial results that could send their stock prices soaring -- or plummeting.

Interactive Chart